The Relative Roles of Growth Hormone and IGF-1 in Controlling Insulin Sensitivity

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2004 Jan 1

PMID 14702105

Citations 71

Authors

David R Clemmons

Affiliations

Soon will be listed here.

Abstract

IGF-1 and growth hormone (GH) interact with insulin to modulate its control of carbohydrate metabolism. A new study (see the related article beginning on page 96) shows that blocking the effect of GH in the presence of low serum IGF-1 concentrations enhances insulin sensitivity.

Citing Articles

Insulin-Like Growth Factor Signaling in Alzheimer's Disease: Pathophysiology and Therapeutic Strategies.

Miao J, Zhang Y, Su C, Zheng Q, Guo J Mol Neurobiol. 2024; 62(3):3195-3225.

PMID: 39240280 PMC: 11790777. DOI: 10.1007/s12035-024-04457-1.

Medaka liver developed Human NAFLD-NASH transcriptional signatures in response to ancestral bisphenol A exposure.

Chakraborty S, Anand S, Bhandari R Res Sq. 2024; .

PMID: 39070641 PMC: 11275980. DOI: 10.21203/rs.3.rs-4585175/v1.

Cardiovascular protection of YiyiFuzi powder and the potential mechanisms through modulating mitochondria-endoplasmic reticulum interactions.

Ding J, Ji R, Wang Z, Jia Y, Meng T, Song X Front Pharmacol. 2024; 15:1405545.

PMID: 38978978 PMC: 11228702. DOI: 10.3389/fphar.2024.1405545.

Sex-specific expression of the human NAFLD-NASH transcriptional signatures in the liver of medaka with a history of ancestral bisphenol A exposure.

Chakraborty S, Anand S, Bhandari R bioRxiv. 2024; .

PMID: 38826193 PMC: 11142124. DOI: 10.1101/2024.05.19.594843.

Insulin Resistance: The Increased Risk of Cancers.

Szablewski L Curr Oncol. 2024; 31(2):998-1027.

PMID: 38392069 PMC: 10888119. DOI: 10.3390/curroncol31020075.

References

Yakar S, Setser J, Zhao H, Stannard B, Haluzik M, Glatt V . Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest. 2004; 113(1):96-105. PMC: 300761. DOI: 10.1172/JCI17763. View

Haluzik M, Yakar S, Gavrilova O, Setser J, Boisclair Y, LeRoith D . Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. Diabetes. 2003; 52(10):2483-9. DOI: 10.2337/diabetes.52.10.2483. View

Rizza R, Mandarino L, Gerich J . Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes. 1982; 31(8 Pt 1):663-9. DOI: 10.2337/diab.31.8.663. View

Guler H, Zapf J, FROESCH E . Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med. 1987; 317(3):137-40. DOI: 10.1056/NEJM198707163170303. View

Edge J, Dunger D, Matthews D, Gilbert J, Smith C . Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab. 1990; 71(5):1356-62. DOI: 10.1210/jcem-71-5-1356. View

Morrow L, OBrien M, Moller D, Flier J, Moses A . Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance. J Clin Endocrinol Metab. 1994; 79(1):205-10. DOI: 10.1210/jcem.79.1.8027228. View

Ezzat S, Forster M, Berchtold P, Redelmeier D, Boerlin V, Harris A . Acromegaly. Clinical and biochemical features in 500 patients. Medicine (Baltimore). 1994; 73(5):233-40. View

Weaver J, Monson J, Noonan K, John W, Edwards A, Evans K . The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab. 1995; 80(1):153-9. DOI: 10.1210/jcem.80.1.7829604. View

Laron Z, Avitzur Y, Klinger B . Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment. Metabolism. 1995; 44(10 Suppl 4):113-8. DOI: 10.1016/0026-0495(95)90231-7. View

10.

Moses A, Young S, Morrow L, OBrien M, Clemmons D . Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes. 1996; 45(1):91-100. DOI: 10.2337/diab.45.1.91. View

11.

Dominici F, Cifone D, Bartke A, Turyn D . Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone-transgenic mice. J Endocrinol. 1999; 161(3):383-92. DOI: 10.1677/joe.0.1610383. View

12.

Kim J, Michael M, Previs S, Peroni O, Mauvais-Jarvis F, Neschen S . Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest. 2000; 105(12):1791-7. PMC: 378504. DOI: 10.1172/JCI8305. View

13.

Laron Z . The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome. J Clin Endocrinol Metab. 1999; 84(12):4397-404. DOI: 10.1210/jcem.84.12.6255. View

14.

Isley W, Underwood L, Clemmons D . Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest. 1983; 71(2):175-82. PMC: 436855. DOI: 10.1172/jci110757. View

15.

Yakar S, Liu J, Fernandez A, Wu Y, Schally A, Frystyk J . Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes. 2001; 50(5):1110-8. DOI: 10.2337/diabetes.50.5.1110. View

16.

Fernandez A, Kim J, Yakar S, Dupont J, Hernandez-Sanchez C, Castle A . Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev. 2001; 15(15):1926-34. PMC: 312754. DOI: 10.1101/gad.908001. View

17.

OConnell T, Clemmons D . IGF-I/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms. J Clin Endocrinol Metab. 2002; 87(9):4356-60. DOI: 10.1210/jc.2002-020343. View

18.

Holt R, Simpson H, Sonksen P . The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabet Med. 2003; 20(1):3-15. DOI: 10.1046/j.1464-5491.2003.00827.x. View

19.

Tatar M, Bartke A, Antebi A . The endocrine regulation of aging by insulin-like signals. Science. 2003; 299(5611):1346-51. DOI: 10.1126/science.1081447. View

20.

Williams R, Amin R, Shojaee-Moradie F, Umpleby A, Acerini C, Dunger D . The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with Type 1 diabetes mellitus. Diabetologia. 2003; 46(9):1203-10. DOI: 10.1007/s00125-003-1175-8. View